Redefining interferon-producing killer dendritic cells as a novel intermediate in NK-cell differentiation.
暂无分享,去创建一个
[1] I. Weissman,et al. Identification of the earliest natural killer cell-committed progenitor in murine bone marrow. , 2011, Blood.
[2] K. Takeda,et al. Natural killer (NK)–dendritic cell interactions generate MHC class II-dressed NK cells that regulate CD4+ T cells , 2011, Proceedings of the National Academy of Sciences.
[3] M. Albert,et al. Cutting Edge: A Dual Role for Type I IFNs during Polyinosinic-Polycytidylic Acid-Induced NK Cell Activation , 2011, The Journal of Immunology.
[4] F. Takei,et al. Unique progenitors in mouse lymph node develop into CD127+ NK cells: thymus-dependent and thymus-independent pathways. , 2011, Blood.
[5] M. Leid,et al. An Early T Cell Lineage Commitment Checkpoint Dependent on the Transcription Factor Bcl11b , 2010, Science.
[6] M. Caligiuri,et al. CD94 Defines Phenotypically and Functionally Distinct Mouse NK Cell Subsets1 , 2009, The Journal of Immunology.
[7] John Anderson,et al. Migratory and antigen presentation functions of IFN-producing killer dendritic cells. , 2009, Cancer research.
[8] F. Collins,et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits , 2009, Proceedings of the National Academy of Sciences.
[9] C. Roth,et al. Maturation of mouse NK cells is a 4-stage developmental program. , 2009, Blood.
[10] T. Waldmann,et al. Interleukin-15 combined with an anti-CD40 antibody provides enhanced therapeutic efficacy for murine models of colon cancer , 2009, Proceedings of the National Academy of Sciences.
[11] M. Chagnon,et al. Cutting Edge: Genetic Characterization of IFN-Producing Killer Dendritic Cells1 , 2009, The Journal of Immunology.
[12] R. Eeles,et al. Genome-wide association studies in cancer. , 2008, Human molecular genetics.
[13] A. Veillette,et al. Control of T Lymphocyte Signaling by Ly108, a Signaling Lymphocytic Activation Molecule Family Receptor Implicated in Autoimmunity* , 2008, Journal of Biological Chemistry.
[14] L. Zitvogel,et al. Trans-Presentation of IL-15 Dictates IFN-Producing Killer Dendritic Cells Effector Functions1 , 2008, The Journal of Immunology.
[15] M. Smyth,et al. Application of CD27 as a marker for distinguishing human NK cell subsets. , 2008, International immunology.
[16] R. V. van Lier,et al. CD27 Defines Phenotypically and Functionally Different Human NK Cell Subsets , 2008, The Journal of Immunology.
[17] Melanie Bahlo,et al. Development of plasmacytoid and conventional dendritic cell subtypes from single precursor cells derived in vitro and in vivo , 2007, Nature Immunology.
[18] M. Colonna,et al. Development and function of murine B220+CD11c+NK1.1+ cells identify them as a subset of NK cells , 2007, The Journal of experimental medicine.
[19] S. Nutt,et al. Putative IKDCs are functionally and developmentally similar to natural killer cells, but not to dendritic cells , 2007, The Journal of experimental medicine.
[20] O. Mandelboim,et al. CD11cloB220+ interferon-producing killer dendritic cells are activated natural killer cells , 2007, The Journal of experimental medicine.
[21] N. Huntington,et al. Developmental pathways that generate natural-killer-cell diversity in mice and humans , 2007, Nature Reviews Immunology.
[22] B. Kee,et al. Interferon-producing killer dendritic cells (IKDCs) arise via a unique differentiation pathway from primitive c-kitHiCD62L+ lymphoid progenitors. , 2007, Blood.
[23] Hubertus Hochrein,et al. Production of interferons by dendritic cells, plasmacytoid cells, natural killer cells, and interferon-producing killer dendritic cells. , 2007, Blood.
[24] A. Cumano,et al. A thymic pathway of mouse natural killer cell development characterized by expression of GATA-3 and CD127 , 2006, Nature Immunology.
[25] F. Powrie,et al. Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology. , 2006, Immunity.
[26] M. Smyth,et al. CD27 Dissects Mature NK Cells into Two Subsets with Distinct Responsiveness and Migratory Capacity1 , 2006, The Journal of Immunology.
[27] L. Lanier,et al. Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity , 2006, Nature Medicine.
[28] P. Opolon,et al. A novel dendritic cell subset involved in tumor immunosurveillance , 2006, Nature Medicine.
[29] J. D. Di Santo,et al. Distinguishing features of developing natural killer cells. , 2005, Current opinion in immunology.
[30] E. Puré,et al. The regulation and activation of CD44 by natural killer (NK) cells and its role in the production of IFN-gamma. , 2004, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[31] Gordon K Smyth,et al. Statistical Applications in Genetics and Molecular Biology Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments , 2011 .
[32] J. Dorfman,et al. Turnover and Proliferation of NK Cells in Steady State and Lymphopenic Conditions1 , 2004, The Journal of Immunology.
[33] Brad T. Sherman,et al. DAVID: Database for Annotation, Visualization, and Integrated Discovery , 2003, Genome Biology.
[34] M. Farrar,et al. In Vivo Survival and Homeostatic Proliferation of Natural Killer Cells , 2003, The Journal of experimental medicine.
[35] W. Yokoyama,et al. In vivo developmental stages in murine natural killer cell maturation , 2002, Nature Immunology.
[36] A. Cumano,et al. Identification of committed NK cell progenitors in adult murine bone marrow , 2001, European journal of immunology.
[37] H. Ruley,et al. Ly108: a new member of the mouse CD2 family of cell surface proteins , 2000, Immunogenetics.
[38] D. Fearon,et al. A subpopulation of B220+ cells in murine bone marrow does not express CD19 and contains natural killer cell progenitors , 1996, The Journal of experimental medicine.
[39] J. A. Hobbs,et al. Fas involvement in cytotoxicity mediated by human NK cells. , 1995, Cellular immunology.
[40] E. Ciccone,et al. CD69-mediated pathway of lymphocyte activation: anti-CD69 monoclonal antibodies trigger the cytolytic activity of different lymphoid effector cells with the exception of cytolytic T lymphocytes expressing T cell receptor alpha/beta , 1991, The Journal of experimental medicine.
[41] Robert W. McDivitt,et al. A proposed classification of breast cancer based on kinetic information derived from a comparison of risk factors in 168 primary operable breast cancers , 1986, Cancer.
[42] A Krishan,et al. Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining , 1975, The Journal of cell biology.
[43] Stephen J Chanock,et al. Genome-wide association studies in cancer--current and future directions. , 2010, Carcinogenesis.
[44] A. Veillette. Immune regulation by SLAM family receptors and SAP-related adaptors , 2006, Nature Reviews Immunology.
[45] W. Liang,et al. TM4 microarray software suite. , 2006, Methods in enzymology.
[46] W. Liang,et al. 9) TM4 Microarray Software Suite , 2006 .
[47] F. Sutterwala,et al. Transforming growth factor-beta controls T helper type 1 cell development through regulation of natural killer cell interferon-gamma. , 2005, Nature immunology.
[48] Lewis L Lanier,et al. NK cell recognition. , 2005, Annual review of immunology.
[49] R. Hardy,et al. B cell development pathways. , 2001, Annual review of immunology.